Teresa López‐Fernández

Author

Also Known As

A. Nemes, C. Medrano, E. Samset, Elena Galli, Fernández, Tomás, Gonzalo de la Morena, J. Caro Codon, Jaime Feliu Batlle, Joshua Levenson, López-Fernández T

334

Publications

15.5K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario La Paz Hospital La Paz Institute for Health Research University of Liège Royal Brompton Hospital Centro de Investigación en Red en Enfermedades Cardiovasculares

About

Teresa López‐Fernández is an author at Hospital Universitario La Paz specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	790
2	Public Health	6	6	118
3	Health Sciences	3	3	66
4	Engineering	1	1	20
5	Diabetes	1	1	30

Teresa López‐Fernández

Publications

12.1K

Citations

H-Index

Page 1

	Year	Citations
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines José Luis Zamorano, Patrizio Lancellotti, Daniel Muñoz, European Heart Journal	2016	2.5K
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, European Heart Journal	2022	2.4K
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines José Luis Zamorano, Patrizio Lancellotti, Daniel Muñoz, European Journal of Heart Failure	2016	1.8K
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society Alexander R. Lyon, Susan Dent, Susannah Stanway, European Journal of Heart Failure	2020	717
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement Joerg Herrmann, Daniel J. Lenihan, Saro H. Armenian, European Heart Journal Heart FailureOncologyCardiovascular ToxicitiesCardiovascular DiseaseAtherosclerosis	2021	542
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, European Heart Journal - Cardiovascular Imaging	2022	459
Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC) Jelena Čelutkienė, Radek Pudil, Teresa López‐Fernández, European Journal of Heart Failure	2020	349
Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study Tadafumi Sugimoto, Raluca Dulgheru, Anne Bernard, European Heart Journal - Cardiovascular Imaging	2017	340
Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study Roberta Manganaro, Stella Marchetta, Raluca Dulgheru, European Heart Journal - Cardiovascular Imaging	2018	332
Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology Radek Pudil, Christian Mueller, Jelena Čelutkienė, European Journal of Heart Failure	2020	325

Page 1